Market Overview:
The global polycystic ovarian syndrome (PCOS) treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of PCOS, rising awareness about PCOS, and technological advancements in the field of PCOS treatment. The global polycystic ovarian syndrome (PCOS) treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into oral contraceptives, antiandrogens, insulin-sensitizing agent, antidepressant, anti-obesity drugs and others. Oral contraceptives are further sub-segmented into combined oral contraceptive pills (COCPs), progestin-only pills (POPs), and extended cycle regimens COCPs). On the basis of application,the market is segmented into ovarian wedge resection surgery laparoscopic ovarian drilling surgery and other applications such as fertility treatments etc.). The North America region dominatesthe global polycystic ovary syndrome(PCOS)treatmentmarket followed by Europeand Asia Pacificregion owingto high prevalenceof PCOStreatmentin these regions coupled with increasing awareness about this disorder among people living there .
 Treatment Industry Outlook.svg)
Product Definition:
Polycystic Ovarian Syndrome (PCOS) is a hormonal disorder that can cause infertility, weight gain and acne. Polycystic Ovarian Syndrome (PCOS) Treatment is important because it can help regulate your hormones, which may help you lose weight and improve your fertility.
Oral Contraceptives:
Oral Contraceptives, also known as Pills or Oral Drugs are used to prevent pregnancy. They may be used by women as young as 15 years and older than 40 years of age. The average age of menopause across the globe is 51 years; however, it varies from woman to woman.
Antiandrogens:
Antiandrogens are a group of drugs that act as anti-estrogen. They are used in the treatment of Polycystic Ovary Syndrome (PCOS) which is a hormonal disorder responsible for irregular menstrual cycles, infertility, and obesity. The drug class also includes propionate & nonopioid antiandrogens such as Sogroya and Nolvadex.
Application Insights:
The others segment dominated the market for PCOS treatment and accounted for a revenue share of more than 30.0% in 2017. This is owing to the availability of various other options, such as lifestyle modification, dietetic modifications and medical management, which are not covered under other segments. The ovarian wedge resection surgery is one of the most preferred treatments for polycystic ovary syndrome due to its effectiveness in eliminating cysts and improving symptoms associated with this condition. However, this procedure is only available at certain hospitals/clinics depending upon their capabilities; hence it cannot be performed at home like laparoscopic surgeries can be done at any hospital or clinic owing to their non-invasive nature.
The laparoscopic ovarian drilling technique has been found more effective than open surgery in treating patients with polycystic ovary syndrome due to lesser postoperative pain.
Regional Analysis:
Europe dominated the global market in 2017 owing to the presence of a large patient pool and well-established healthcare infrastructure. Moreover, rising awareness about PCOS among people is expected to fuel regional growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period due to increasing disposable income and healthcare expenditure in emerging countries such as India and China. Growing medical tourism industry in these countries will also contribute towards regional demand for PCOS treatment. Furthermore, an increase in infertility rate coupled with growing awareness about available treatments will boost market development further.
Growth Factors:
- Increasing prevalence of PCOS
- Growing awareness about PCOS and its treatment options
- Rising demand for minimally invasive procedures for PCOS treatment
- Technological advancements in the field of PCOS treatment
- Availability of government funding for research on PCOS
Scope Of The Report
Report Attributes
Report Details
Report Title
Polycystic Ovarian Syndrome (PCOS) Treatment Market Research Report
By Type
Oral Contraceptives, Antiandrogens, Insulin-sensitizing Agent, Antidepressant, Anti-obesity, Others
By Application
Ovarian Wedge Resection, Laparoscopic Ovarian Drilling, Others
By Companies
AstraZeneca, Bayer AG, Merck KGaA, Abbott, Sanofi, Pfizer, Bristol-Myer Squibb Company, Novartis AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Polycystic Ovarian Syndrome (PCOS) Treatment Market Report Segments:
The global Polycystic Ovarian Syndrome (PCOS) Treatment market is segmented on the basis of:
Types
Oral Contraceptives, Antiandrogens, Insulin-sensitizing Agent, Antidepressant, Anti-obesity, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ovarian Wedge Resection, Laparoscopic Ovarian Drilling, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- Bayer AG
- Merck KGaA
- Abbott
- Sanofi
- Pfizer
- Bristol-Myer Squibb Company
- Novartis AG
 Treatment Market Overview.svg)
Highlights of The Polycystic Ovarian Syndrome (PCOS) Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Contraceptives
- Antiandrogens
- Insulin-sensitizing Agent
- Antidepressant
- Anti-obesity
- Others
- By Application:
- Ovarian Wedge Resection
- Laparoscopic Ovarian Drilling
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polycystic Ovarian Syndrome (PCOS) Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Treatment Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for PCOS will vary depending on the individual's symptoms and medical history. However, some common treatments for PCOS include weight loss, birth control pills, and testosterone therapy.
Some of the major companies in the polycystic ovarian syndrome (pcos) treatment market are AstraZeneca, Bayer AG, Merck KGaA, Abbott, Sanofi, Pfizer, Bristol-Myer Squibb Company, Novartis AG.
The polycystic ovarian syndrome (pcos) treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Polycystic Ovarian Syndrome (PCOS) Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Polycystic Ovarian Syndrome (PCOS) Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Polycystic Ovarian Syndrome (PCOS) Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Polycystic Ovarian Syndrome (PCOS) Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Polycystic Ovarian Syndrome (PCOS) Treatment Market Size & Forecast, 2018-2028
4.5.1 Polycystic Ovarian Syndrome (PCOS) Treatment Market Size and Y-o-Y Growth
4.5.2 Polycystic Ovarian Syndrome (PCOS) Treatment Market Absolute $ Opportunity
Chapter 5 Global Polycystic Ovarian Syndrome (PCOS) Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Type
5.2.1 Oral Contraceptives
5.2.2 Antiandrogens
5.2.3 Insulin-sensitizing Agent
5.2.4 Antidepressant
5.2.5 Anti-obesity
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Polycystic Ovarian Syndrome (PCOS) Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Applications
6.2.1 Ovarian Wedge Resection
6.2.2 Laparoscopic Ovarian Drilling
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Polycystic Ovarian Syndrome (PCOS) Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Polycystic Ovarian Syndrome (PCOS) Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Type
9.6.1 Oral Contraceptives
9.6.2 Antiandrogens
9.6.3 Insulin-sensitizing Agent
9.6.4 Antidepressant
9.6.5 Anti-obesity
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Applications
9.10.1 Ovarian Wedge Resection
9.10.2 Laparoscopic Ovarian Drilling
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Polycystic Ovarian Syndrome (PCOS) Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Type
10.6.1 Oral Contraceptives
10.6.2 Antiandrogens
10.6.3 Insulin-sensitizing Agent
10.6.4 Antidepressant
10.6.5 Anti-obesity
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Applications
10.10.1 Ovarian Wedge Resection
10.10.2 Laparoscopic Ovarian Drilling
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Polycystic Ovarian Syndrome (PCOS) Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Type
11.6.1 Oral Contraceptives
11.6.2 Antiandrogens
11.6.3 Insulin-sensitizing Agent
11.6.4 Antidepressant
11.6.5 Anti-obesity
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Applications
11.10.1 Ovarian Wedge Resection
11.10.2 Laparoscopic Ovarian Drilling
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Polycystic Ovarian Syndrome (PCOS) Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Type
12.6.1 Oral Contraceptives
12.6.2 Antiandrogens
12.6.3 Insulin-sensitizing Agent
12.6.4 Antidepressant
12.6.5 Anti-obesity
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Applications
12.10.1 Ovarian Wedge Resection
12.10.2 Laparoscopic Ovarian Drilling
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Polycystic Ovarian Syndrome (PCOS) Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Type
13.6.1 Oral Contraceptives
13.6.2 Antiandrogens
13.6.3 Insulin-sensitizing Agent
13.6.4 Antidepressant
13.6.5 Anti-obesity
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Polycystic Ovarian Syndrome (PCOS) Treatment Market Size Forecast by Applications
13.10.1 Ovarian Wedge Resection
13.10.2 Laparoscopic Ovarian Drilling
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Polycystic Ovarian Syndrome (PCOS) Treatment Market: Competitive Dashboard
14.2 Global Polycystic Ovarian Syndrome (PCOS) Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca
14.3.2 Bayer AG
14.3.3 Merck KGaA
14.3.4 Abbott
14.3.5 Sanofi
14.3.6 Pfizer
14.3.7 Bristol-Myer Squibb Company
14.3.8 Novartis AG
